UB Paderborn / Katalog / Suche / in CDI

1 – 21 von 21

Sortiert nach

Long-term proteasome inhibition in US community multiple myeloma (MM) patients (pts) following in-class transition (iCT) from parenteral bortezomib (V) to oral ixazomib (I): Updated real-world (RW) data from US MM-6

Journal of clinical oncology, 2020-05, Vol.38 (15_suppl), p.e19332-e19332

2020

Volltextzugriff (PDF)

A megastudy of text-based nudges encouraging patients to get vaccinated at an upcoming doctor's appointment

Proceedings of the National Academy of Sciences - PNAS, 2021-05, Vol.118 (20), p.1

2021

Volltextzugriff (PDF)

Satellite and airborne remote sensing of gross primary productivity in boreal Alaskan lakes

Environmental research letters, 2020-10, Vol.15 (10), p.105001

2020

Volltextzugriff (PDF)

A Randomized Trial of Behavioral Nudges Delivered Through Text Messages to Increase Influenza Vaccination Among Patients With an Upcoming Primary Care Visit

American journal of health promotion, 2023-03, Vol.37 (3), p.324-332

2023

Volltextzugriff (PDF)

In-Class Transition (iCT) from Parenteral Bortezomib to Oral Ixazomib Therapy in Newly Diagnosed Multiple Myeloma (NDMM) Patients from the Community-Based US MM-6 Study: Subgroup Analyses of the Fully Accrued Dataset in Patients Aged <75 and ≥75 Years

Blood, 2022-11, Vol.140 (Supplement 1), p.7322-7323

2022

Volltextzugriff (PDF)

PB2089: IN‐CLASS TRANSITION FROM PARENTERAL BORTEZOMIB TO ORAL IXAZOMIB IN NEWLY DIAGNOSED MULTIPLE MYELOMA (NDMM) ACCORDING TO AGE AND FRAILTY STATUS: UPDATED SUBGROUP ANALYSIS OF US MM‐6

HemaSphere, 2023-08, Vol.7 (S3), p.e149880d-n/a

2023

Volltextzugriff (PDF)

P-114 In-class transition (iCT) from parenteral bortezomib (V) to oral ixazomib in multiple myeloma (MM) by age and frailty status: updated subgroup analysis from the fully accrued US MM-6 study

Clinical lymphoma, myeloma and leukemia, 2023-09, Vol.23, p.S97-S98

2023

Volltextzugriff (PDF)

Environmental sustainability in national food-based dietary guidelines: a global review

The Lancet. Planetary health, 2022-12, Vol.6 (12), p.e977-e986

2022

Volltextzugriff (PDF)

MM-465 In-Class Transition (iCT) from Parenteral Bortezomib-Based Induction to All-Oral Ixazomib-Lenalidomide-Dexamethasone in Transplant-Ineligible Patients With Newly Diagnosed Multiple Myeloma (NDMM): Updated Subgroup Analysis from the Community-Based US MM-6 Study

Clinical lymphoma, myeloma and leukemia, 2023-09, Vol.23, p.S501-S501

2023

Volltextzugriff (PDF)

POSTER: MM-465 In-Class Transition (iCT) from Parenteral Bortezomib-Based Induction to All-Oral Ixazomib-Lenalidomide-Dexamethasone in Transplant-Ineligible Patients With Newly Diagnosed Multiple Myeloma (NDMM): Updated Subgroup Analysis from the Community-Based US MM-6 Study

Clinical lymphoma, myeloma and leukemia, 2023-09, Vol.23, p.S221-S221

2023

Volltextzugriff (PDF)

P947: COMPARATIVE EFFECTIVENESS OF ORAL IXAZOMIB‐LENALIDOMIDE‐DEXAMETHASONE (IRD) AFTER INITIAL BORTEZOMIB (V)‐BASED INDUCTION VS PARENTERAL V‐BASED THERAPY IN NEWLY DIAGNOSED MULTIPLE MYELOMA (NDMM)

HemaSphere, 2022-06, Vol.6 (Suppl), p.837-838

2022

Volltextzugriff (PDF)

MM-233 Evaluation of the Comparative Effectiveness of In-Class Transition (iCT) to All-Oral Ixazomib-Lenalidomide-Dexamethasone (IRd) After Bortezomib (V)-Based Induction Therapy vs Patients Who Continued to Receive Parenteral V-Based Therapy in Newly Diagnosed Multiple Myeloma (NDMM)

Clinical lymphoma, myeloma and leukemia, 2022-10, Vol.22, p.S415

2022

Volltextzugriff (PDF)

Poster: MM-233 Evaluation of the Comparative Effectiveness of In-Class Transition (iCT) to ALL-Oral Ixazomib-Lenalidomide-Dexamethasone (IRd) After Bortezomib (V)-Based Induction Therapy vs Patients Who Continued to Receive Parenteral V-Based Therapy in Newly Diagnosed Multiple Myeloma (NDMM)

Clinical lymphoma, myeloma and leukemia, 2022-10, Vol.22, p.S179

2022

Volltextzugriff (PDF)

P-196: In-class transition (iCT) from bortezomib (V)-based induction to oral ixazomib-lenalidomidedexamethasone vs parenteral V-based therapy: comparative effectiveness in newly diagnosed multiple myeloma

Clinical lymphoma, myeloma and leukemia, 2022-08, Vol.22, p.S143

2022

Volltextzugriff (PDF)

Correction: On the Relationship Between Aquatic CO2 Concentration and Ecosystem Fluxes in Some of the World’s Key Wetland Types

Wetlands (Wilmington, N.C.), 2024-08, Vol.44 (6), p.76, Article 76

2024

Volltextzugriff (PDF)

Seafood in Food Security: A Call for Bridging the Terrestrial-Aquatic Divide

Frontiers in sustainable food systems, 2022-01, Vol.5

2022

Volltextzugriff (PDF)

On the Relationship Between Aquatic CO2 Concentration and Ecosystem Fluxes in Some of the World’s Key Wetland Types

Wetlands (Wilmington, N.C.), 2024, Vol.44 (1), p.1, Article 1

2024

Volltextzugriff (PDF)

225th ENMC International Workshop: A global FSHD Registry framework 18-20 November 2016, Heemskerk, The Netherlands

Neuromuscular disorders : NMD, 2017-08, Vol.27 (8), p.782-790

2017

Volltextzugriff (PDF)

225th ENMC international workshop

Neuromuscular disorders : NMD, 2017-08, Vol.27 (8), p.782-790

2017

Volltextzugriff (PDF)

Students' Problem Solving as Mediated by Their Cognitive Tool Use: A Study of Tool Use Patterns

Journal of Educational Computing Research, 2009-01, Vol.40 (1), p.111-139

2009

Volltextzugriff (PDF)

Experimental Bacillus cereus post-traumatic endophthalmitis and treatment with ciprofloxacin

British journal of ophthalmology, 1996-08, Vol.80 (8), p.755-758

1996

Volltextzugriff (PDF)

1 – 21 von 21

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(21)
Mit Volltextzugriff
(21)

Publikationsform

Artikel
(21)

Sprache

Englisch
(21)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Long-term proteasome inhibition in US community multiple myeloma (MM) patients (pts) following in-class transition (iCT) from parenteral bortezomib (V) to oral ixazomib (I): Updated real-world (RW) data from US MM-6

A megastudy of text-based nudges encouraging patients to get vaccinated at an upcoming doctor's appointment

Satellite and airborne remote sensing of gross primary productivity in boreal Alaskan lakes

A Randomized Trial of Behavioral Nudges Delivered Through Text Messages to Increase Influenza Vaccination Among Patients With an Upcoming Primary Care Visit

In-Class Transition (iCT) from Parenteral Bortezomib to Oral Ixazomib Therapy in Newly Diagnosed Multiple Myeloma (NDMM) Patients from the Community-Based US MM-6 Study: Subgroup Analyses of the Fully Accrued Dataset in Patients Aged <75 and ≥75 Years

PB2089: IN‐CLASS TRANSITION FROM PARENTERAL BORTEZOMIB TO ORAL IXAZOMIB IN NEWLY DIAGNOSED MULTIPLE MYELOMA (NDMM) ACCORDING TO AGE AND FRAILTY STATUS: UPDATED SUBGROUP ANALYSIS OF US MM‐6

P-114 In-class transition (iCT) from parenteral bortezomib (V) to oral ixazomib in multiple myeloma (MM) by age and frailty status: updated subgroup analysis from the fully accrued US MM-6 study

Environmental sustainability in national food-based dietary guidelines: a global review

MM-465 In-Class Transition (iCT) from Parenteral Bortezomib-Based Induction to All-Oral Ixazomib-Lenalidomide-Dexamethasone in Transplant-Ineligible Patients With Newly Diagnosed Multiple Myeloma (NDMM): Updated Subgroup Analysis from the Community-Based US MM-6 Study

POSTER: MM-465 In-Class Transition (iCT) from Parenteral Bortezomib-Based Induction to All-Oral Ixazomib-Lenalidomide-Dexamethasone in Transplant-Ineligible Patients With Newly Diagnosed Multiple Myeloma (NDMM): Updated Subgroup Analysis from the Community-Based US MM-6 Study

P947: COMPARATIVE EFFECTIVENESS OF ORAL IXAZOMIB‐LENALIDOMIDE‐DEXAMETHASONE (IRD) AFTER INITIAL BORTEZOMIB (V)‐BASED INDUCTION VS PARENTERAL V‐BASED THERAPY IN NEWLY DIAGNOSED MULTIPLE MYELOMA (NDMM)

MM-233 Evaluation of the Comparative Effectiveness of In-Class Transition (iCT) to All-Oral Ixazomib-Lenalidomide-Dexamethasone (IRd) After Bortezomib (V)-Based Induction Therapy vs Patients Who Continued to Receive Parenteral V-Based Therapy in Newly Diagnosed Multiple Myeloma (NDMM)

Poster: MM-233 Evaluation of the Comparative Effectiveness of In-Class Transition (iCT) to ALL-Oral Ixazomib-Lenalidomide-Dexamethasone (IRd) After Bortezomib (V)-Based Induction Therapy vs Patients Who Continued to Receive Parenteral V-Based Therapy in Newly Diagnosed Multiple Myeloma (NDMM)

P-196: In-class transition (iCT) from bortezomib (V)-based induction to oral ixazomib-lenalidomidedexamethasone vs parenteral V-based therapy: comparative effectiveness in newly diagnosed multiple myeloma

Correction: On the Relationship Between Aquatic CO2 Concentration and Ecosystem Fluxes in Some of the World’s Key Wetland Types

Seafood in Food Security: A Call for Bridging the Terrestrial-Aquatic Divide

On the Relationship Between Aquatic CO2 Concentration and Ecosystem Fluxes in Some of the World’s Key Wetland Types

225th ENMC International Workshop: A global FSHD Registry framework 18-20 November 2016, Heemskerk, The Netherlands

225th ENMC international workshop

Students' Problem Solving as Mediated by Their Cognitive Tool Use: A Study of Tool Use Patterns

Experimental Bacillus cereus post-traumatic endophthalmitis and treatment with ciprofloxacin

Suchergebnisse filtern